# Study of Anlotinib in Non-squamous NSCLC Patients Who Failed First-Line（ALTER-L020）

> **NCT03755869** · PHASE4 · UNKNOWN · sponsor: **First Affiliated Hospital Xi'an Jiaotong University** · enrollment: 103 (estimated)

## Conditions studied

- Non-squamous NSCLC

## Interventions

- **DRUG:** Anlotinib

## Key facts

- **NCT ID:** NCT03755869
- **Lead sponsor:** First Affiliated Hospital Xi'an Jiaotong University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-11-29
- **Primary completion:** 2021-11
- **Final completion:** 2021-12
- **Target enrollment:** 103 (ESTIMATED)
- **Last updated:** 2020-04-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03755869

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03755869, "Study of Anlotinib in Non-squamous NSCLC Patients Who Failed First-Line（ALTER-L020）". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03755869. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*